SCHEMBL2493857

SCHEMBL2493857

Cc1ccccc1-c1cccc(CN2CCNCC2)c1-c1ccccc1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.66
HTR7 P34969 4/20 0.50
KMT2A Q03164 2/20 0.45
SIGMAR1 Q99720 1/20 0.45
HTR1A P08908 1/20 0.45
CYP2A13 Q16696 1/20 0.44
ACHE P22303 1/20 0.43
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
CYP1A2 P05177 2/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
TSHR P16473 1/20 0.42
RECQL P46063 1/20 0.42
SLC6A4 P31645 2/20 0.41
SLC6A2 P23975 1/20 0.41
ADRB1 P08588 1/20 0.41
HTR6 P50406 3/20 0.40
PTPN11 Q06124 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491500 0.87 KMT2A (0.49) LMNAHTR7KMT2ACYP2A13ACHE
SCHEMBL2491547 0.85 ALDH1A1 (0.49) LMNAHTR7KMT2ACYP2A13ACHE
SCHEMBL593284 0.81 LMNA (0.96) LMNAKMT2ASIGMAR1CYP2A13ACHE
SCHEMBL2492302 0.80 MPO (0.50) LMNASIGMAR1SLC6A4SLC6A2HTR6
Hydrochloric Acid SCHEMBL7417639 0.80 LMNA (1.00) LMNAKMT2ASIGMAR1CYP2A13ACHE
Hydrochloric Acid SCHEMBL2924720 0.80 LMNA (1.00) LMNAKMT2ASIGMAR1CYP2A13ACHE
SCHEMBL2490806 0.80 HTR7 (0.54) LMNAHTR7CYP1A2CYP2D6SLC6A4
SCHEMBL3962172 0.79 LMNA (0.73) LMNAKMT2ASIGMAR1HTR1ACYP2A13
SCHEMBL14818737 0.76 LMNA (0.84) LMNAKMT2ASIGMAR1CYP2A13ACHE
SCHEMBL29863134 0.76 LMNA (0.84) LMNAKMT2ASIGMAR1CYP2A13ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH LMNA 2547/4885HTR7 241/4885KMT2A 2108/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 LMNA 2843/4885HTR7 164/4885KMT2A 2219/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R LMNA 2187/4885HTR7 178/4885KMT2A 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.